A Wars2 Mutant Mouse Model Displays OXPHOS Deficiencies and Activation of Tissue-Specific Stress Response Pathways

Summary: Mutations in genes essential for mitochondrial function have pleiotropic effects. The mechanisms underlying these traits yield insights into metabolic homeostasis and potential therapies. Here we report the characterization of a mouse model harboring a mutation in the tryptophanyl-tRNA synt...

Full description

Bibliographic Details
Main Authors: Thomas Agnew, Michelle Goldsworthy, Carlos Aguilar, Anna Morgan, Michelle Simon, Helen Hilton, Chris Esapa, Yixing Wu, Heather Cater, Liz Bentley, Cheryl Scudamore, Joanna Poulton, Karl J. Morten, Kyle Thompson, Langping He, Steve D.M. Brown, Robert W. Taylor, Michael R. Bowl, Roger D. Cox
Format: Article
Language:English
Published: Elsevier 2018-12-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124718318710
id doaj-630a0a3d696840bfb3f385b49f594bbc
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Thomas Agnew
Michelle Goldsworthy
Carlos Aguilar
Anna Morgan
Michelle Simon
Helen Hilton
Chris Esapa
Yixing Wu
Heather Cater
Liz Bentley
Cheryl Scudamore
Joanna Poulton
Karl J. Morten
Kyle Thompson
Langping He
Steve D.M. Brown
Robert W. Taylor
Michael R. Bowl
Roger D. Cox
spellingShingle Thomas Agnew
Michelle Goldsworthy
Carlos Aguilar
Anna Morgan
Michelle Simon
Helen Hilton
Chris Esapa
Yixing Wu
Heather Cater
Liz Bentley
Cheryl Scudamore
Joanna Poulton
Karl J. Morten
Kyle Thompson
Langping He
Steve D.M. Brown
Robert W. Taylor
Michael R. Bowl
Roger D. Cox
A Wars2 Mutant Mouse Model Displays OXPHOS Deficiencies and Activation of Tissue-Specific Stress Response Pathways
Cell Reports
author_facet Thomas Agnew
Michelle Goldsworthy
Carlos Aguilar
Anna Morgan
Michelle Simon
Helen Hilton
Chris Esapa
Yixing Wu
Heather Cater
Liz Bentley
Cheryl Scudamore
Joanna Poulton
Karl J. Morten
Kyle Thompson
Langping He
Steve D.M. Brown
Robert W. Taylor
Michael R. Bowl
Roger D. Cox
author_sort Thomas Agnew
title A Wars2 Mutant Mouse Model Displays OXPHOS Deficiencies and Activation of Tissue-Specific Stress Response Pathways
title_short A Wars2 Mutant Mouse Model Displays OXPHOS Deficiencies and Activation of Tissue-Specific Stress Response Pathways
title_full A Wars2 Mutant Mouse Model Displays OXPHOS Deficiencies and Activation of Tissue-Specific Stress Response Pathways
title_fullStr A Wars2 Mutant Mouse Model Displays OXPHOS Deficiencies and Activation of Tissue-Specific Stress Response Pathways
title_full_unstemmed A Wars2 Mutant Mouse Model Displays OXPHOS Deficiencies and Activation of Tissue-Specific Stress Response Pathways
title_sort wars2 mutant mouse model displays oxphos deficiencies and activation of tissue-specific stress response pathways
publisher Elsevier
series Cell Reports
issn 2211-1247
publishDate 2018-12-01
description Summary: Mutations in genes essential for mitochondrial function have pleiotropic effects. The mechanisms underlying these traits yield insights into metabolic homeostasis and potential therapies. Here we report the characterization of a mouse model harboring a mutation in the tryptophanyl-tRNA synthetase 2 (Wars2) gene, encoding the mitochondrial-localized WARS2 protein. This hypomorphic allele causes progressive tissue-specific pathologies, including hearing loss, reduced adiposity, adipose tissue dysfunction, and hypertrophic cardiomyopathy. We demonstrate the tissue heterogeneity arises as a result of variable activation of the integrated stress response (ISR) pathway and the ability of certain tissues to respond to impaired mitochondrial translation. Many of the systemic metabolic effects are likely mediated through elevated fibroblast growth factor 21 (FGF21) following activation of the ISR in certain tissues. These findings demonstrate the potential pleiotropy associated with Wars2 mutations in patients. : A reduced-function mutation in the nuclear-encoded, mitochondrial-localized Wars2 gives rise to deafness, reduced and abnormal fat, and hypertrophic cardiomyopathy. Agnew et al. show that the different tissue effects of this mutation arise from variable activation of stress response pathways and tissue-specific responses to impaired mitochondrial function. Keywords: WARS2, deafness, adiposity, hypertrophic cardiomyopathy, pleiotropic, ISR, mitochondrial dysfunction
url http://www.sciencedirect.com/science/article/pii/S2211124718318710
work_keys_str_mv AT thomasagnew awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT michellegoldsworthy awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT carlosaguilar awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT annamorgan awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT michellesimon awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT helenhilton awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT chrisesapa awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT yixingwu awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT heathercater awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT lizbentley awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT cherylscudamore awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT joannapoulton awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT karljmorten awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT kylethompson awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT langpinghe awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT stevedmbrown awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT robertwtaylor awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT michaelrbowl awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT rogerdcox awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT thomasagnew wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT michellegoldsworthy wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT carlosaguilar wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT annamorgan wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT michellesimon wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT helenhilton wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT chrisesapa wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT yixingwu wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT heathercater wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT lizbentley wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT cherylscudamore wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT joannapoulton wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT karljmorten wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT kylethompson wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT langpinghe wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT stevedmbrown wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT robertwtaylor wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT michaelrbowl wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
AT rogerdcox wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways
_version_ 1724905104317874176
spelling doaj-630a0a3d696840bfb3f385b49f594bbc2020-11-25T02:13:27ZengElsevierCell Reports2211-12472018-12-01251233153328.e6A Wars2 Mutant Mouse Model Displays OXPHOS Deficiencies and Activation of Tissue-Specific Stress Response PathwaysThomas Agnew0Michelle Goldsworthy1Carlos Aguilar2Anna Morgan3Michelle Simon4Helen Hilton5Chris Esapa6Yixing Wu7Heather Cater8Liz Bentley9Cheryl Scudamore10Joanna Poulton11Karl J. Morten12Kyle Thompson13Langping He14Steve D.M. Brown15Robert W. Taylor16Michael R. Bowl17Roger D. Cox18MRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKNuffield Department of Obstetrics and Gynaecology, University of Oxford, Level 3 The Women’s Centre, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UKNuffield Department of Obstetrics and Gynaecology, University of Oxford, Level 3 The Women’s Centre, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UKWellcome Centre for Mitochondrial Research, Institute of Neuroscience, The Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UKWellcome Centre for Mitochondrial Research, Institute of Neuroscience, The Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKWellcome Centre for Mitochondrial Research, Institute of Neuroscience, The Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UK; Corresponding authorMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UK; Corresponding authorSummary: Mutations in genes essential for mitochondrial function have pleiotropic effects. The mechanisms underlying these traits yield insights into metabolic homeostasis and potential therapies. Here we report the characterization of a mouse model harboring a mutation in the tryptophanyl-tRNA synthetase 2 (Wars2) gene, encoding the mitochondrial-localized WARS2 protein. This hypomorphic allele causes progressive tissue-specific pathologies, including hearing loss, reduced adiposity, adipose tissue dysfunction, and hypertrophic cardiomyopathy. We demonstrate the tissue heterogeneity arises as a result of variable activation of the integrated stress response (ISR) pathway and the ability of certain tissues to respond to impaired mitochondrial translation. Many of the systemic metabolic effects are likely mediated through elevated fibroblast growth factor 21 (FGF21) following activation of the ISR in certain tissues. These findings demonstrate the potential pleiotropy associated with Wars2 mutations in patients. : A reduced-function mutation in the nuclear-encoded, mitochondrial-localized Wars2 gives rise to deafness, reduced and abnormal fat, and hypertrophic cardiomyopathy. Agnew et al. show that the different tissue effects of this mutation arise from variable activation of stress response pathways and tissue-specific responses to impaired mitochondrial function. Keywords: WARS2, deafness, adiposity, hypertrophic cardiomyopathy, pleiotropic, ISR, mitochondrial dysfunctionhttp://www.sciencedirect.com/science/article/pii/S2211124718318710